A searchable database of
medically documented cases

About the Project

Liver cancer

liver cancer

Epidemiology:

Hepatocellular carcinoma (HCC), the most common form of liver cancer, is a significant global health issue. It is the sixth most frequently diagnosed cancer and the fourth leading cause of cancer-related death worldwide, accounting for over 700,000 deaths annually¹.

Liver cancer often develops in people with pre-existing chronic liver diseases, especially cirrhosis. The most common underlying causes include chronic infection with hepatitis B virus (HBV) and hepatitis C virus (HCV), excessive alcohol consumption, and non-alcoholic fatty liver disease (NAFLD), which is often linked to obesity and type 2 diabetes².

Spontaneous remission (SR) of any type of cancer is an extremely rare phenomenon and its frequency is difficult to estimate in medical practice. It has been reported that SR may account for less than 2% of all reported cases of SR of neoplasms³. Irrespective of cancer type or histopathology, SR is a very rarely reported phenomenon within the medical profession. Because cases of SR tend to be reported only when the “regression is both dramatic and durable [and] less dramatic regressions, for many reasons, tend to get overlooked and are almost never reported”⁴. It is therefore difficult to estimate the frequency with which liver cancer undergoes SR as part of its natural history. By definition, SR is the complete or partial disappearance or regression of cancer without any treatment that could be credited with its remission. Due to its rarity and the tendency for only the most "dramatic and durable" cases to be reported, the true frequency of SR in liver cancer is likely underestimated.

Clinical Characteristics:

To date, there have been 100 reported cases of SR of either primary or metastatic liver cancer. There are several clinical trends that may be observed among these cases. The patients’ age at the time of regression ranges from 14 to 92 years with a peak incidence of 60-70 years of age. Males showed much higher rates (2:1) of SR of CRC, with all cases of SR from rectal cancers occurring in males. See table 1 below for further information.

Histological and Imaging Characteristics

The predominant histological diagnosis is hepatocellular carcinoma (HCC), with tumors exhibiting varying levels of differentiation, including well-differentiated, moderately differentiated, and poorly differentiated forms. Other tumor types were not included in this analysis.

Imaging findings consistently show the presence of one or more heterogeneous masses in the liver, most commonly located in the right hepatic lobe. Common laboratory findings include elevated serum levels of the tumor markers alpha-fetoprotein (AFP) and PIVKA-II, as well as elevated liver enzymes such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST).

Proposed Contributing Mechanisms

The following factors are proposed to contribute to the spontaneous regression of liver cancer, with the number of cases citing each mechanism detailed below:

  • Vascular/Ischemia (36 cases): This is the most frequently proposed mechanism. It is believed that a disturbance in the tumor's blood supply, caused by factors such as portal vein thrombosis, hemorrhage-induced ischemia, or arterial embolization, leads to tumor infarction and necrosis, which results in subsequent regression.
  • Immune Response (20 cases): This mechanism suggests that the patient's own immune system is responsible for the regression. Evidence for this includes histological findings of lymphocyte infiltration, macrophage overactivation, and an overall anti-tumoral immune reaction.
  • Other/Systemic Factors (16 cases): Various other systemic factors are mentioned, including hormonal changes(postpartum), the use of specific herbal medicines, vitamin K administration, radiation therapy, systemic viral clearance, and hemodynamic changes associated with dialysis.
  • No Reported Mechanism (30 cases): A significant portion of the cases is described as having no definitive cause for their regression, with some being explicitly labeled as "truly spontaneous" or "unspecified."

Site and extent of regressions

In the 102 cases of spontaneous regression (SR) of liver cancer, a majority of patients experienced complete regression of their tumors, with all evidence of the lesion disappearing on follow-up imaging. Several cases, however, showed a partial regression, with the tumors shrinking significantly but not fully resolving.

The site and extent of the regression varied:

  • Primary Tumor Only (62 cases): The regression was confined to the primary hepatic lesion.
  • Metastases Only (11 cases): The SR was observed exclusively in metastatic sites, such as lung nodules or enlarged lymph nodes, with no change to the primary liver tumor.
  • Primary and Metastases (29 cases): In these cases, both the primary liver tumor and its metastases regressed simultaneously.

The follow-up period for these patients ranged from months to over a decade, with many surviving for several years after the documented SR event.

Table 1: CRC SR Cases and Clinical Characteristics

Author–year

Age/sex

Primary site

Remission site

Proposed mechanisms

Follow-up

Alqutub, 20115

65/M

Right hepatic lobe

Right hepatic lobe

Local ischemia and hemorrhagic necrosis

14 weeks

Arora & Madhusudhana et al., 20116

54/M

Right hepatic lobe

None reported

4 years

Bastawrous et al., 20127

63/M

Right hepatic lobe

Right hepatic lobe

Vascular etiology related to hemorrhage-induced ischaemia

10 months

Bhardwaj et al., 20148

74/F

Inferior left hepatic lobe

Liver

19 months

Jang et al., 20009

54/F

Right hepatic lobe

Ischemia from cirrhotic changes

Kim, 201510

57/M

Liver

Liver

Immune response

Lim et al., 201411

64/M

Liver

Lung & adrenal metastases

None reported

No recurrent lesions

Matsuoka et al., 201512

67/M

Liver

Liver

Spontaneous regression

Regular visits for over 3 years, no recurrence

Mcdermott & Khettry et al., 199413

23/F

Liver

Liver

Regression or differentiation

20 years

Meza-Junco et al., 200714

56/F

Liver

Liver

Disturbance of blood supply

Nakajima, 200415

80/M

Liver

Liver

Local ischemia

Noij et al., 201716

74/M

Liver

None reported

6 months

Nouso et al., 200517

85/M

Liver

Liver

Blood shortage or vitamin K effect

5 months

Ohtani, 201518

69/M

Liver

Liver

Disturbance of blood supply

9 months

Okano & Ohana et al., 201519

73/M

Liver

Liver

Ischemia secondary to angiography

No mass at 6 months

Okano, 201320

77/M

Liver

Liver

Disruption of feeding artery

One month

Saito, 201421

75/M

Liver

Lung metastases

None reported

15 months

Tocci, 199022

79/M

Liver

Liver

Severe hemorrhagic shock

Tumor disappeared after 3 years

Uenishi, 200023

65/M

Liver

Liver

Disturbance in portal venous and hepatic artery flow

1 year

Wang, 201524

50/M

Liver

Overactivation of CD163+ macrophages

Yang, 201525

56/M

Liver

Liver

T-cell immunity restoration

1 month

Yano, 200526

71/F

Liver

Local hepatic factor

Feo, 201427

71/F

Liver

Liver

Tumour infarction secondary to vascular occlusion

3 months

Sasaki, 201328

79/M

Liver

Liver

Alam, 200429

61/M

Liver

Liver

Immune-mediated mechanism

5 months

Blondon, 200430

64/M

Liver

Liver

Immune activation

3 months

Blondon, 200430

70/F

Liver

Liver

None

18 months

Cheng, 200431

74/M

Liver

Left hepatic lobe

None

9 months

Chiesara, 201432

65/M

Liver

Liver

Herbal medicine, ischaemic and inflammatory processes

1 year, symptom-free

Clos, 201733

72/M

Liver

Liver

None

3 months

Del & Oggio et al., 200934

77/F

Liver

Liver

Strong immunologic reaction

Reduction in lesion size, AFP normalization

Gomez & Anz et al., 199835

66/M

Liver

Intraabdominal and cutaneous masses

Possible immune mechanism

16 months

Grossmann, 199536

52/M

Liver

Liver

14 months

Harimoto, 201237

73/M

Liver

Lung metastases

Extended posterior segmentectomy

5 months

Ikuta, 200238

60/M

Colon

Liver

Tumor necrosis

9 months

Kaczynski, 199839

73/M

Liver

None

15 months

Kato, 200440

77/M

Liver

Lungs

None

4 months

Kato, 200440

72/M

Liver

Liver

None

2 years

Kojima, 200641

79/M

Liver

Lung metastases

Antitumor effects of P. linteus

6 months

Komatsu, 201242

65/M

Liver

Liver

2 years

Kondo, 200643

70/M

Liver

One more later, CT showed viable tumor volume shrinkage, and the AFP level decreased

Kondo, 200643

75/M

Liver

Lung metastases

4 months

Kondo, 200643

67/M

Liver

Liver

1 year after relapse

Kondo, 200643

67/M

Liver

Lung metastases

6 months

Lee, 200044

44/M

Liver

Liver

Intratumoral event

5 months

Lee, 200044

63/M

Liver

Liver

Intratumoral event

3 years

Li, 200345

53/M

Liver

Inflammatory reaction

Luciani, 200146

77/M

Liver

Liver

Tumor necrosis

30 months, well

Misawa, 199947

62/M

Liver

Tumor necrosis

2 years

Nakai, 200148

76/M

Liver

Liver

Immunological mechanism

Nakayama, 201249

92/F

Liver

Liver

Immune response

Nam, 200550

65/M

Liver

Liver and skull

Tumor necrosis and immune modulation

10 months

Nishijima, 200951

86/F

Liver

Liver

Tumor necrosis

4 months

Ohta, 200552

74/M

Liver

Liver

Necrosis due to cholangitis

Oquinena, 200953

4/M

Liver

Hepatic circulation disturbance

Oquinena, 200953

61/M

Liver

Liver

Hepatic circulation disturbance

Complete remission in July 2005

Oquinena, 200953

60/M

Liver

Liver

Hepatic circulation disturbance

Park, 200954

57/M

Liver

Liver

Local immune reactions

Pectasides, 201655

53/M

Liver

Lung metastases

Tumor ischemia + immune response

Peddu, 200856

57/M

Liver

Liver

Auto-infarction

No evidence of HCC

Randolph, 200857

56/M

Liver

Immune response or compromised blood supply

35 days

Rene, 199258

67/M

Liver

Ischemia

2 years

Sibartie, 200859

76/M

Liver

Liver

autoembolization

Stefanczyk-Sapieha, 200860

56/M

Liver

Liver

none

Stoelben, 199861

56/M

Liver

Liver

Immune stimulation

Stoelben, 199861

74/M

Liver

Liver

Immune stimulation

Storey, 201162

52/M

Liver

Lung metastases

Immune system

9 months

Takeda, 200063

68/M

Liver

Liver

1 month

Tsai, 201464

74/M

Liver

2.5 years

Ushigome et al., 200765

60/M

Liver

Aneurysm

Slow blood flow

Kogiso et al., 200066

50/F

Liver

Immunological response

Kogiso et al., 200066

52/M

Liver

Liver

Immunological response

Resolved by day 115 after LT

L'Huillier, 202467

70/M

Liver

Liver

Immunologic reactions

2 years

Franses, 202168

64/M

Liver

Immunologic reactions

9 weeks

Arjunan, 202169

65/F

Liver

Liver

Immune response

Liu, 202070

67/M

Liver

Lung metastasis

Immune activation

19 months

Ghattu, 202271

64/M

Liver

Liver masses and lung nodules

Ischemia and immunologic presentation

Several months later

Ghattu, 202271

65/M

Liver

Liver mass

Ischemia and immunologic presentation

15 months in hospice

Ghattu, 202271

57/F

Liver

Liver lesion

Ischemia and immunologic response

Costa-Santos, 202072

68/M

Liver

Liver

Cytotoxic activity

10 months

Sonabre, 202073

74/M

Liver

Vascular phenomena and immunologic pathways

1 year

Singh, 202274

43/M

Liver

Liver

Tumor necrosis

Singh, 202274

54/M

Liver

Liver

Outgrowing blood supply

Tumor shrinkage observed

Muroya, 202175

78/M

Liver

Lung

Hemodynamic changes from dialysis

13 months

Xu, 202376

81/F

Lung and Liver

Lung and Liver

Self-anti-tumor immune response

14 months

Kimura, 202177

84/F

Liver

Liver

Immune reaction

Kawaguchi, 201978

56/M

Liver

Liver

Improvement of insulin resistance

10 weeks

Koya, 201879

83/M

Liver

Liver

Decreased blood flow and hypoxia

16 months

Yamamoto, 202280

84/F

Liver

Liver

Tumor necrosis

5 months

Hirata, 202581

73/F

Liver

Liver

Tumor necrosis, immune response

7 months

Chohan, 201982

79/F

Liver

Lung

None reported

2 months

Shishimoto, 202383

71/M

Liver

Liver EHE lesions

Biliary decompression

12 months

Oshima, 202584

67/M

Liver, lung, pancreas

Liver mass

Immune response

4 months

Meares, 197985

64/M

Reduction of anxiety triggers remission

2 months

Gottfried et al., 198286

65/M

Liver

Abstention from alcohol

Lam et al., 198287

50/M

Liver

Involution and tissue replacement

Asymptomatic and free from recurrence

Sato et al., 198588

78/M

Femur fracture site

Ayres et al., 199089

63/F

Liver

12 months

Mcsweeney et al., 197390

5.5/M

Liver

Liver

2 years

Pardes et al., 198291

7.5/M

Liver

Spontaneous regression

8 months

Penkava & Rothenberg et al., 198192

55/F

Buhler et al., 198293

32/F

Liver

Discontinuation of contraceptives

Normal liver examination and enzymes

Author–year

Age/sex

Primary site

Remission site

Proposed mechanisms

Follow-up

References:

  1. Forner, A., et al. "Hepatocellular carcinoma." The Lancet 391.10127 (2018): 1301-1314.
  2. El-Serag, H. B., and K. L. Kanwal. "Epidemiology of hepatocellular carcinoma." Clinics in Liver Disease 22.2 (2018): 253-264.
  3. Cole, W. H. "Spontaneous regression of cancer." Annals of the New York Academy of Sciences 114.2 (1964): 742-750.
  4. Everson, T. C., and W. H. Cole. Spontaneous regression of cancer. WB Saunders, 1966.
  5. Alqutub, A., Peck, D., & Marotta, P. (2011). spontaneous regression of a large hepatocellular carcinoma: case report. German medical science : GMS e-journal, 9, Doc07. https://doi.org/10.3205/000130
  6. Arora, N., & Madhusudhana, S. (2011). spontaneous regression of hepatocellular cancer: case report and review of literature. Gastrointestinal cancer research : GCR, 4(4), 141–143.
  7. Bastawrous, S., Kogut, M. J., & Bhargava, P. (2012). spontaneous regression of hepatocellular carcinoma in a cirrhotic patient: possible vascular hypothesis. Singapore medical journal, 53(10), e218–e221.
  8. Bhardwaj, N., Li, M., Price, T., & Maddern, G. J. (2014). spontaneous regression of a biopsy confirmed hepatocellular carcinoma. BMJ case reports, 2014, bcr2014204897. https://doi.org/10.1136/bcr-2014-204897
  9. Jang, T. J., Lee, J. I., Kim, D. H., Kim, J. R., & Lee, H. K. (2000). spontaneous regression of hepatocellular carcinoma--a case report. The Korean journal of internal medicine, 15(2), 147–150. https://doi.org/10.3904/kjim.2000.15.2.147
  10. Kim, S. B., Kang, W., Shin, S. H., Lee, H. S., Lee, S. H., Choi, G. H., & Park, J. Y. (2015). spontaneous neoplastic remission of hepatocellular carcinoma. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 65(5), 312–315. https://doi.org/10.4166/kjg.2015.65.5.312
  11. Lim, D. H., Park, K. W., & Lee, S. I. (2014). spontaneous complete regression of multiple metastases of hepatocellular carcinoma: A case report. Oncology letters, 7(4), 1225–1228. https://doi.org/10.3892/ol.2014.1869
  12. Matsuoka, S., Tamura, A., Moriyama, M., Fujikawa, H., Mimatsu, K., Oida, T., & Sugitani, M. (2015). Pathological evidence of the cause of spontaneous regression in a case of resected hepatocellular carcinoma. Internal medicine (Tokyo, Japan), 54(1), 25–30. https://doi.org/10.2169/internalmedicine.54.2981
  13. McDermott, W. V., & Khettry, U. (1994). Clear cell carcinoma of the liver with spontaneous regression of metastases. Journal of surgical oncology, 57(3), 206–209. https://doi.org/10.1002/jso.2930570315
  14. Meza-Junco, J., monthstaño-Loza, A. J., MARTinez-Benítez, B., & Cabrera-Aleksandrova, T. (2007). spontaneous partial regression of hepatocellular carcinoma in a cirrhotic patient. Annals of hepatology, 6(1), 66–69. https://doi.org/10.1016/S1665-2681(19)31957-X
  15. Nakajima, T., Moriguchi, M., Watanabe, T., Noda, M., Fuji, N., Minami, M., Itoh, Y., & Okanoue, T. (2004). Recurrence of hepatocellular carcinoma with rapid growth after spontaneous regression. World journal of gastroenterology, 10(22), 3385–3387. https://doi.org/10.3748/wjg.v10.i22.3385
  16. Noij, D. P., & van Der Linden, P. W. (2017). spontaneous regression of hepatocellular carcinoma in a Caucasian male patient: A case report and review of the literature. Molecular and clinical oncology, 6(2), 225–228. https://doi.org/10.3892/mco.2016.1115
  17. Nouso, K., Uematsu, S., Shiraga, K., Okamoto, R., Harada, R., Takayama, S., Kawai, W., Kimura, S., Ueki, T., Okano, N., Nakagawa, M., Mizuno, M., Araki, Y., & Shiratori, Y. (2005). Regression of hepatocellular carcinoma during vitamin K administration. World journal of gastroenterology, 11(42), 6722–6724. https://doi.org/10.3748/wjg.v11.i42.6722
  18. Ohtani, H., Yamazaki, O., Matsuyama, M., Horii, K., Shimizu, S., Oka, H., Nebiki, H., Kioka, K., Kurai, O., Kawasaki, Y., Manabe, T., Murata, K., Matsuo, R., & Inoue, T. (2005). spontaneous regression of hepatocellular carcinoma: report of a case. Surgery today, 35(12), 1081–1086. https://doi.org/10.1007/s00595-005-3066-8
  19. Okano, A., & Ohana, M. (2015). spontaneous regression of hepatocellular carcinoma: its imaging course leading to complete disappearance. Case reports in oncology, 8(1), 94–100. https://doi.org/10.1159/000375486
  20. Okano, A., Ohana, M., Kusumi, F., & Nabeshima, M. (2013). spontaneous Regression of Hepatocellular Carcinoma due to Disrupatiention of the Feeding artery. Case reports in oncology, 6(1), 180–185. https://doi.org/10.1159/000350682
  21. Saito, T., Naito, M., Matsumura, Y., Kita, H., Kanno, T., Nakada, Y., Hamano, M., Chiba, M., Maeda, K., Michida, T., & Ito, T. (2014). spontaneous regression of a large hepatocellular carcinoma with multiple lung metastases. Gut and liver, 8(5), 569–574. https://doi.org/10.5009/gnl13358
  22. Tocci, G., Conte, A., Guarascio, P., & Visco, G. (1990). spontaneous remission of hepatocellular carcinoma after massive gastrointestinal haemorrhage. BMJ (Clinical research ed.), 300(6725), 641–642. https://doi.org/10.1136/bmj.300.6725.641
  23. Uenishi, T., Hirohashi, K., Tanaka, H., Ikebe, T., & Kinoshita, H. (2000). spontaneous regression of a large hepatocellular carcinoma with portal vein tumor thrombi: report of a case. Surgery today, 30(1), 82–85. https://doi.org/10.1007/PL00010054
  24. Wang, Z., Ke, Z. F., Lu, X. F., Luo, C. J., Liu, Y. D., Lin, Z. W., & Wang, L. T. (2015). The clue of a possible etiology about spontaneous regression of hepatocellular carcinoma: a perspective on pathology. OncoTargets and therapy, 8, 395–400. https://doi.org/10.2147/OTT.S79102
  25. Yang, S. Z., Zhang, W., Yuan, W. S., & Dong, J. H. (2015). Recurrence of Hepatocellular Carcinoma With Epithelial-Mesenchymal Transition After spontaneous Regression: A Case report. Medicine, 94(28), e1062. https://doi.org/10.1097/MD.0000000000001062
  26. Yano, Y., Yamashita, F., Kuwaki, K., Fukumori, K., Kato, O., Ki-year-old maleatsu, K., Sakai, T., Yamamoto, H., Yamasaki, F., Ando, E., & Sata, M. (2005). partial spontaneous regression of hepatocellular carcinoma: a case with high concentrations of serum lens culinaris agglutinin-reactive alpha fetoprotein. The Kurume medical journal, 52(3), 97–103. https://doi.org/10.2739/kurumemedj.52.97
  27. Feo, C. F., Marrosu, A., Scanu, A. M., Ginesu, G. C., Fancellu, A., Migaleddu, V., & Porcu, A. (2004). spontaneous regression of hepatocellular carcinoma: report of a case. European journal of gastroenterology & hepatology, 16(9), 933–936. https://doi.org/10.1097/00042737-200409000-00020
  28. Sasaki, T., Fukumori, D., Yamamoto, K., Yamamoto, F., Igimi, H., & Yamashita, Y. (2013). Management considerations for purporighted spontaneous regression of hepatocellular carcinoma: a case report. Case reports in gastroenterology, 7(1), 147–152. https://doi.org/10.1159/000350501
  29. Blondon, H., Fritsch, L., & Cherqui, D. (2004). Two cases of spontaneous regression of multicentric hepatocellular carcinoma after intraperitoneal rupture: possible role of immune mechanisms. European journal of gastroenterology & hepatology, 16(12), 1355–1359. https://doi.org/10.1097/00042737-200412000-00020
  30. Blondon, H., Fritsch, L., & Cherqui, D. (2004). Two cases of spontaneous regression of multicentric hepatocellular carcinoma after intraperitoneal rupture: possible role of immune mechanisms. European journal of gastroenterology & hepatology, 16(12), 1355–1359. https://doi.org/10.1097/00042737-200412000-00020
  31. Cheng, H. M., & Tsai, M. C. (2004). Regression of hepatocellular carcinoma spontaneous or herbal medicine related?. The American journal of Chinese medicine, 32(4), 579–585. https://doi.org/10.1142/S0192415X04002211
  32. Chiesara, F., Spagnolo, A., Koch, M., & Moretti, A. (2014). A case of hepatocellular carcinoma: spontaneous regression?. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 46(7), 659–660. https://doi.org/10.1016/j.dld.2014.02.007
  33. Clos, A., Hernández, A., Sánchez, M. D., Tenesa, M., Julián, J. F., Armengol, C., & Sala, M. (2017). spontaneous regression of hepatocellular carcinoma. A case report. Regresión espotaneousánea de carcinoma hepatocelular. A propósito de un caso. Gastroenterologia y hepatologia, 40(4), 286–288. https://doi.org/10.1016/j.gastrohep.2016.02.003
  34. Del Poggio, P., Mattiello, M., Gilardoni, L., Jamoletti, C., Colombo, S., & Zabbialini, G. (2009). The mysterious case of spontaneous disappearance of hepatocellular carcinoma. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 41(7), e21–e25. https://doi.org/10.1016/j.dld.2008.02.001
  35. Gómez Sanz, R., Moreno Gonzalez, E., Colina Ruiz-Delgado, F., Garcia-Muñoz, H., Ochando Cerdan, F., & Gonzalez-Pinto, I. (1998). spontaneous regression of a recurrent hepatocellular carcinoma. Digestive diseases and sciences, 43(2), 323–328. https://doi.org/10.1023/a:1018802321581
  36. Grossmann, M., Hoermann, R., Weiss, M., Jauch, K. W., Oerightel, H., Staebler, A., Mann, K., & Engelhardt, D. (1995). spontaneous regression of hepatocellular carcinoma. The American journal of gastroenterology, 90(9), 1500–1503. https://doi.org/10.1046/j.1365-2559.1998.00340.x
  37. Harimoto, N., Shirabe, K., Kajiyama, K., Gion, T., Takenaka, M., Nagaie, T., & Maehara, Y. (2012). spontaneous regression of multiple pulmonary recurrences of hepatocellular carcinoma after hepatectomy: report of a case. Surgery today, 42(5), 475–478. https://doi.org/10.1007/s00595-011-0030-7
  38. Ikuta, S., Miki, C., Ookura, E., Tonouchi, H., & Kusunoki, M. (2002). spontaneous regression of a metastatic liver tumor: report of a case. Surgery today, 32(9), 844–848. https://doi.org/10.1007/s005950200165
  39. Kaczynski, J., Hansson, G., Remotti, H., & Wallerstedt, S. (1998). spontaneous regression of hepatocellular carcinoma. Histopathology, 32(2), 147–150. https://doi.org/10.1046/j.1365-2559.1998.00340.x
  40. Kato, H., Nakamura, M., Muramatsu, M., Orito, E., Ueda, R., & Mizokami, M. (2004). spontaneous regression of hepatocellular carcinoma: two case reports and a literature review. Hepatology research : the official journal of the Japan Society of Hepatology, 29(3), 180–190. https://doi.org/10.1016/j.hepres.2004.03.005
  41. Kojima, H., Tanigawa, N., Kariya, S., Komemushi, A., Shomura, Y., Sawada, S., Arai, E., & Yokota, Y. (2006). A case of spontaneous regression of hepatocellular carcinoma with multiple lung metastases. Radiation medicine, 24(2), 139–142. https://doi.org/10.1007/BF02493281
  42. Komatsu, H., Imamura, S., Shimizu, T., Tsunoda, Y., Ito, T., Imai, J., Nagakubo, S., Morohoshi, Y., & Fujita, Y. (2012). spontaneous regression of hepatocellular carcinoma repeated 3 times with invasion of portal vein and inferior vena cava: report on a rare case. Clinical journal of gastroenterology, 5(1), 35–41. https://doi.org/10.1007/s12328-011-0266-1
  43. Kondo, S., Okusaka, T., Ueno, H., Ikeda, M., & Morizane, C. (2006). spontaneous regression of hepatocellular carcinoma. International journal of clinical oncology, 11(5), 407–411. https://doi.org/10.1007/s10147-006-0591-4
  44. Lee, H. S., Lee, J. S., Woo, G. W., Yoon, J. H., & Kim, C. Y. (2000). Recurrent hepatocellular carcinoma after spontaneous regression. Journal of gastroenterology, 35(7), 552–556. https://doi.org/10.1007/s005350070080
  45. Li, A. J., Wu, M. C., Cong, W. M., Shen, F., & Yi, B. (2003). spontaneous complete necrosis of hepatocellular carcinoma: a case report. Hepatobiliary & pancreatic diseases international : HBPD INT, 2(1), 152–154.
  46. Luciani, A., Rahmouni, A., Achab, H., Mathieu, D., Jazaerli, N., & Bouanane, M. (2001). CT de monthstration of the spontaneous regression of a hypervascular lesion in cirrhotic liver. Cancer imaging : the official publication of the International Cancer Imaging Society, 1(2), 1–3. https://doi.org/10.1102/1470-7330.2001.001
  47. Misawa, K., Hata, Y., Manabe, K., Matsuoka, S., Saito, M., Takada, J., & Sano, F. (1999). spontaneous regression of hepatocellular carcinoma. Journal of gastroenterology, 34(3), 410–414. https://doi.org/10.1007/s005350050285
  48. Nakai, T., Shimomura, T., & Hirokawa, F. (2001). spontaneous regression of recurrent hepatocellular carcinoma after TAE: possible mechanisms of immune mediation. International journal of clinical oncology, 6(3), 149–152. https://doi.org/10.1007/pl00012098
  49. Nakayama S. (2012). spontaneous regression of hepatocellular carcinoma. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 31(5), 267–270. https://doi.org/10.1007/s12664-012-0220-2
  50. Nam, S. W., Han, J. Y., Kim, J. I., Park, S. H., Cho, S. H., Han, N. I., Yang, J. M., Kim, J. K., Choi, S. W., Lee, Y. S., Chung, K. W., & Sun, H. S. (2005). spontaneous regression of a large hepatocellular carcinoma with skull metastasis. Journal of gastroenterology and hepatology, 20(3), 488–492. https://doi.org/10.1111/j.1440-1746.2005.03243.x
  51. Nishijima, N., Marusawa, H., Kita, R., Osaki, Y., & Chiba, T. (2009). Education and Imaging. Hepatobiliary and pancreatic: spontaneous regression of hepatocellular cancer demonstrated by contrast-enhanced ultrasonography. Journal of gastroenterology and hepatology, 24(6), 1153. https://doi.org/10.1111/j.1440-1746.2009.05884.x
  52. Ohta, H., Sakamoto, Y., Ojima, H., Yamada, Y., Hibi, T., Takahashi, Y., Sano, T., Shimada, K., & Kosuge, T. (2005). spontaneous regression of hepatocellular carcinoma with complete necrosis: case report. abdominal imaging, 30(6), 734–737. https://doi.org/10.1007/s00261-005-0313-9
  53. Oquiñena, S., Iñarrairaegui, M., Vila, J. J., Alegre, F., Zozaya, J. M., & Sangro, B. (2009). spontaneous regression of hepatocellular carcinoma: three case reports and a categorized review of the literature. Digestive diseases and sciences, 54(5), 1147–1153. https://doi.org/10.1007/s10620-008-0447-z
  54. Park, H. S., Jang, K. Y., Kim, Y. K., Cho, B. H., & Moon, W. S. (2009). Hepatocellular carcinoma with massive lymphoid infiltration: a regressing phenomenon?. Pathology, research and practice, 205(9), 648–652. https://doi.org/10.1016/j.prp.2009.01.001
  55. Pectasides, E., Miksad, R., Pyatibrat, S., Srivastava, A., & Bullock, A. (2016). spontaneous Regression of Hepatocellular Carcinoma with Multiple Lung Metastases: A Case report and Review of the Literature. Digestive diseases and sciences, 61(9), 2749–2754. https://doi.org/10.1007/s10620-016-4141-2
  56. Peddu, P., Huang, D., Kane, P. A., Karani, J. B., & Knisely, A. S. (2008). Vanishing liver tumours. Clinical radiology, 63(3), 329–339. https://doi.org/10.1016/j.crad.2007.08.009
  57. Randolph, A. C., Tharalson, E. M., & Gilani, N. (2008). spontaneous regression of hepatocellular carcinoma is possible and might have implications for future therapies. European journal of gastroenterology & hepatology, 20(8), 804–809. https://doi.org/10.1097/MEG.0b013e3282f2bbcc
  58. Reñé Espinet JM, Ruiz González A, Buenestado García J, Rubio Caballero M. Regresión espotaneousánea de un carcinoma hepatocelular [The spontaneous regression of a hepatocellular carcinoma]. Rev Esp Enferm Dig. 1992 Jan;81(1):60-1. Spanish. PMID: 1372172.
  59. SibARTie, V., MoriARTy, J., & Crowe, J. (2008). spontaneous regression of hepatocellular carcinoma. The American journal of gastroenterology, 103(4), 1050–1051. https://doi.org/10.1111/j.1572-0241.2007.01772_14.x
  60. Stefanczyk-Sapieha, L., & Fainsinger, R. L. (2008). Hepatocellular carcinoma: misdiagnosis or spontaneous remission?. Journal of palliative care, 24(1), 55–59. https://doi.org/10.1177/082585970802400108
  61. Stoelben, E., Koch, M., Hanke, S., Lossnitzer, A., Gaerightner, H. J., Schentke, K. U., Bunk, A., & Saeger, H. D. (1998). spontaneous regression of hepatocellular carcinoma confirmed by surgical specimen: report of two cases and review of the literature. Langenbeck's archives of surgery, 383(6), 447–452. https://doi.org/10.1007/s004230050158
  62. Storey, R. E., Huerighta, A. L., Khan, A., & Laber, D. A. (2011). spontaneous complete regression of hepatocellular carcinoma. Medical oncology (Norighthwood, London, England), 28(4), 948–950. https://doi.org/10.1007/s12032-010-9562-8
  63. Takeda, Y., Togashi, H., Shinzawa, H., Miyano, S., Ishii, R., Karasawa, T., Takeda, Y., Saito, T., Saito, K., Haga, H., Matsuo, T., Aoki, M., Mitsuhashi, H., Watanabe, H., & Takahashi, T. (2000). spontaneous regression of hepatocellular carcinoma and review of literature. Journal of gastroenterology and hepatology, 15(9), 1079–1086. https://doi.org/10.1046/j.1440-1746.2000.02202.x
  64. Tsai, S. C., Kao, J. L., & Shiao, C. C. (2014). spontaneous regression of a hepatoma with ring calcification. Acta clinica Belgica, 69(2), 130–131. https://doi.org/10.1179/2295333714Y.0000000011
  65. Ushigome, H., Koshino, K., Sakai, K., Suzuki, T., Nobori, S., Matsuyama, M., Okajima, H., Okamoto, M., & Yoshimura, N. (2011). Rare spontaneous remission of hepatic artery aneurysm following ABO incompatible living donor liver transplantation: a case report. Transplantation proceedings, 43(6), 2424–2427. https://doi.org/10.1016/j.transproceed.2011.05.036
  66. Kogiso, T., Hashimoto, E., Ikarashi, Y., Kodama, K., Taniai, M., Torii, N., Egawa, H., Yamamoto, M., & Tokushige, K. (2015). spontaneous clearance of HCV accompanying hepatitis after liver transplantation. Clinical journal of gastroenterology, 8(5), 323–329. https://doi.org/10.1007/s12328-015-0602-y
  67. L'Huillier, R., Milot, L., & Dumortier, J. (2024). Spontaneous Regression of Hepatocellular Carcinoma. Journal of gastrointestinal and liver diseases : JGLD, 33(3), 307. https://doi.org/10.15403/jgld-5469
  68. Franses, J. W., Bhan, I., Pankaj, A., Ting, D. T., Deshpande, V., & Tanabe, K. (2021). Spontaneous Immune-Mediated Regression of Hepatocellular Carcinoma With High Tumor Mutational Burden. JCO precision oncology, 5, PO.21.00092. https://doi.org/10.1200/PO.21.00092
  69. Arjunan, V., Hansen, A., Deutzmann, A., Sze, D. Y., & Dhanasekaran, R. (2021). Spontaneous Regression of Hepatocellular Carcinoma: When the Immune System Stands Up to Cancer. Hepatology (Baltimore, Md.), 73(4), 1611–1614. https://doi.org/10.1002/hep.31489
  70. Liu, Z., Zou, J. W., Wang, W. L., & Li, Z. (2020). Spontaneous regression of recurrent hepatocellular carcinoma with multiple lung metastases. Journal of cancer research and therapeutics, 16(7), 1710–1713. https://doi.org/10.4103/jcrt.JCRT_766_20
  71. Ghattu, M., Engstrom, B. I., & Hanouneh, I. A. (2022). Spontaneous regression of hepatocellular carcinoma: what three cases of regression and disease reoccurrence can tell US. Radiology case reports, 17(9), 3405–3409. https://doi.org/10.1016/j.radcr.2022.06.086
  72. Costa-Santos, M. P., Gonçalves, A., Ferreira, A. O., & Nunes, J. (2020). Spontaneous regression of hepatocellular carcinoma: myth or reality?. BMJ case reports, 13(2), e233509. https://doi.org/10.1136/bcr-2019-233509
  73. Sonbare, D. J., Bandi, R., Sharma, V., Cacciarelli, T., & Shaikh, O. S. (2020). Spontaneous Regression of Advanced Hepatocellular Carcinoma. Case reports in gastroenterology, 14(3), 491–496. https://doi.org/10.1159/000508847
  74. Singh K. (2022). Spontaneous Regression of Hepatocellular Carcinoma From Autoinfarction and Implications on Liver Transplantation. ACG case reports journal, 9(7), e00825. https://doi.org/10.14309/crj.0000000000000825
  75. Muroya, D., Sato, T., Sakai, H., Hisaka, T., Akagi, Y., & Okuda, K. (2021). Spontaneous regression of lung metastases in hepatocellular carcinoma: A case report. International journal of surgery case reports, 78, 378–381. https://doi.org/10.1016/j.ijscr.2020.12.045
  76. Xu, Y., Bayewitz, A., & Tary-Lehmann, M. (2023). Rapid Dissemination followed by Spontaneous Regression of Metastatic Hepatocellular Carcinoma after Liver Radiofrequency Thermal Ablation: A Case Report with Correlative Immune Assay. Case reports in oncology, 16(1), 129–136. https://doi.org/10.1159/000527229
  77. Kimura, T., Goi, T., Yokoi, S., Ohnishi, K., Togawa, T., Iida, A., Ishida, M., & Sato, Y. (2021). Possible spontaneous regression of hepatocellular carcinoma with unique histopathological features confirmed by surgical resection: a case report. Surgical case reports, 7(1), 162. https://doi.org/10.1186/s40792-021-01246-z
  78. Kawaguchi, T., Nakano, D., Okamura, S., Shimose, S., Hayakawa, M., Niizeki, T., Koga, H., & Torimura, T. (2019). Spontaneous regression of hepatocellular carcinoma with reduction in angiogenesis-related cytokines after treatment with sodium-glucose cotransporter 2 inhibitor in a cirrhotic patient with diabetes mellitus. Hepatology research : the official journal of the Japan Society of Hepatology, 49(4), 479–486. https://doi.org/10.1111/hepr.13247
  79. Koya, Y., Suzuki, T., Tai, M., Ichii, O., Matsuhashi, N., Ejiri, Y., Shibata, M., & Harada, M. (2018). Spontaneous Regression of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Case reports in gastroenterology, 12(2), 411–419. https://doi.org/10.1159/000490661
  80. Yamamoto, N., Yamamoto, C., & Tajitsu, T. (2022). Spontaneous regression of hepatocellular carcinoma in a pure palliative care setting. Journal of general and family medicine, 24(2), 126–128. https://doi.org/10.1002/jgf2.588
  81. Hirata, T., Endo, S., Shirane, N., Kawaguchi, S., & Ohno, K. (2025). Unexpected Spontaneous Regression of Extensively Diffused Hepatocellular Carcinoma. Cureus, 17(2), e79366. https://doi.org/10.7759/cureus.79366
  82. Chohan, M. B. Y., Taylor, N., Coffin, C., Burak, K. W., & Bathe, O. F. (2019). Spontaneous Regression of Hepatocellular Carcinoma and Review of Reports in the Published English Literature. Case reports in medicine, 2019, 9756758. https://doi.org/10.1155/2019/9756758
  83. Shishimoto, T., Oura, S., Motozato, K., Tanaka, H., Takamatsu, S., & Ono, W. (2023). Epithelioid Hemangioendothelioma of the Liver Showing Spontaneous Complete Regression after the Cessation of Methotrexate Intake. Case reports in oncology, 16(1), 628–633. https://doi.org/10.1159/000531133
  84. Oshima, S., Inano, S., Honjo, G., Tabata, S., Fujimoto, M., Haga, H., & Kitano, T. (2025). Spontaneous Regression of Adult Multi-system Langerhans Cell Histiocytosis Presenting as Liver Tumor Rupture. Internal medicine (Tokyo, Japan), 64(8), 1217–1222. https://doi.org/10.2169/internalmedicine.4060-24
  85. Meares, A. 1979. Regression of Cancer of the Rectum After Intensive Meditation. Medical Journal of Australia 2: Nov 17 1979; 539-540
  86. Gottfried et al., 1982. Spontaneous Regression of Hepatocellular Carcinoma. Gastroenterology 82(4): Apr 1982; 770-774
  87. Lam et al., 1982. Spontaneous Regression of Hepatocellular Carcinoma: A Case Study. Cancer 50(2): July 15 1982; 332-336
  88. Sato et al., 1985. A Case of Spontaneous Regression of Hepatocellular Carcinoma with Bone Metastasis. Cancer 56(3): Aug 1 1985; 667-671
  89. Ayres et al., 1990. Spontaneous Regression of Hepatocellular Carcinoma. Gut 31(6): Jun 1990; 722-724. https://doi.org/10.1046/j.1365-2559.1998.00340.x
  90. Mcsweeney et al., 1973. Spontaneous Regression of a Putative Childhood Hepatoma: A Reappraisal. American Journal of Diseases of Children 125(4): April 1973; 596-598
  91. Pardes et al., 1982. Spontaneous Regression of Infantile Hemangioendotheliomatosis of the Liver; Demonstration by Ultrasound. Journal of Ultrasound in Medicine 1(9): Nov-Dec 1982; 349-353
  92. Penkava & Rothenberg, 1981. Spontaneous Resolution of Oral ContraceptiveAssociated Liver Tumor. Journal of Computer Assisted Tomography 5(1): 1981; 102-103
  93. Buhler et al., 1982. Regression of Liver Cell Adenoma:; A Follow-Up Study of Three Consecutive Patients After Discontinuation of Oral Contraceptive Use. Gastroenterology 82(4): Apr 1982; 775-782